de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

Particulate Formulation of Influenza Virus Antigen in the Form of ISCOMs

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86376

Kröber,  T.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86517

Wolff,  M.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Kröber, T., Wolff, M., Hebel, K., Brunner-Weinzierl, M., & Reichl, U. (2009). Particulate Formulation of Influenza Virus Antigen in the Form of ISCOMs. Poster presented at ISPPP 2009, Delray Beach, Florida, USA.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0013-91AE-5
Abstract
Immunostimulating complexes (ISCOMs) are typically 40 nm spherical cage-like particles used as delivery system for vaccine antigens. They are composed of antigen, cholesterol, phospholipid and the built-in adjuvant saponin (Quil A). ISCOMs have been shown to induce strong antigen-specific cellular and humoral immune responses to various antigens in a variety of animal species. Here, the production of ISCOMs containing the hemagglutinin antigen of human influenza A virus is reported. The complexes were evaluated in terms of particle structure and size via transmission electron microscopy (TEM) and dynamic light scattering (DLS). An in house developed assay is used to characterize the in vitro stimulatory properties of ISCOMs on blood-derived human dendritic cells (DC) in comparison to inactivated influenza virus concentrates.